Stem and progenitor cell-mediated tumor selective gene therapy

K S Aboody1, J Najbauer, M K Danks

  • 1Division of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA. kaboody@coh.org

Gene Therapy
|March 29, 2008
PubMed

Insights

Stem cells target tumors, delivering therapeutic genes to fight aggressive cancers. This cell-based therapy shows significant tumor reduction and improved survival in animal models, offering a promising new treatment approach.

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Gene Therapy

Background:

  • Aggressive and metastatic tumors have poor prognoses.
  • Current cancer treatments cause toxic side effects.
  • Need for more effective, tumor-selective therapies.

Purpose of the Study:

  • To investigate the potential of stem/progenitor cells for targeted anticancer gene delivery.
  • To evaluate the efficacy of stem cell-mediated gene therapy in preclinical cancer models.

Main Methods:

  • Utilizing stem cells (neural and mesenchymal) engineered to carry therapeutic genes.
  • Delivering these engineered stem cells to various metastatic tumor models in animals.
  • Assessing tumor volume, animal survival, and disease-free survival rates.

Main Results:

  • Demonstrated significant antitumor responses in animal models.
  • Reported substantial tumor volume reduction (up to 90%).
  • Achieved increased survival and complete cures in some models (e.g., 90% disease-free survival in neuroblastoma).

Conclusions:

  • Stem cells possess inherent tumor-tropic properties for targeted gene delivery.
  • Cell-based gene therapy is a promising strategy for treating invasive and metastatic cancers.
  • Further research into stem cell biology and gene product efficacy will enhance clinical utility.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...